Thomas Sandmann has extensive experience in the field of discovery technologies and genomics, holding senior director and principal scientist positions at Denali Therapeutics. Prior roles include senior scientist at Verily/Google Life Sciences and various computational biology roles at Genentech, where expertise in bioinformatics was developed. Thomas also conducted postdoctoral research at both the German Cancer Research Centre and Temasek Life Science Laboratories. Academically, Thomas holds a PhD in Biology from Heidelberg University and a Diplom in Biochemistry from Eberhard-Karls-University, Tübingen, Germany.